VITA 34 International AG: VITA 34 expanding into Slovenia
VITA 34 International AG / Alliance Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Leipzig, February 11, 2009 – VITA 34 International AG (ISIN DE000A0BL849), the parent company of the leading umbilical cord blood bank within the German-speaking countries VITA 34 AG, is expanding into Slovenia. VITA 34 AG is partnering with Izvorna celica d.o.o. in the EU country. It will be in charge of marketing activities in Slovenia as well as conducting training at fertility clinics on extracting umbilical cord blood. This is then processed into a preparation at the VITA 34 lab in Leipzig, where it is put into cryoconservation and stored at very low temperatures. VITA 34 is expecting the first inflow to the bank from Slovenia, which counts around 20,000 births every year, in the first half of 2009. This move marks another step towards VITA 34 entering further European countries in line with its plans. In addition to Germany, the Leipzig-based company already operates in Spain, Austria and Switzerland. 2009 is to see expansion to one further European market in addition to Slovenia. Press/ Investor Relations: Axel Mühlhaus Dr. Sönke Knop edicto GmbH Zeißelstraße 19 D-60318 Frankfurt Tel.:+49 (069) 90550550 Fax: +49 (069) 90550577 eMail: vita34@edicto.de 11.02.2009 Financial News transmitted by DGAP ---------------------------------------------------------------------- Language: English Issuer: VITA 34 International AG Deutscher Platz 5a 04103 Leipzig Deutschland Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: info@vita34.de Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------